Price T Rowe Associates Inc. MD Lowers Position in Utah Medical Products, Inc. (NASDAQ:UTMD)

Price T Rowe Associates Inc. MD lowered its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD) by 32.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 15,213 shares of the medical instruments supplier’s stock after selling 7,227 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Utah Medical Products were worth $936,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Barclays PLC increased its position in shares of Utah Medical Products by 214.1% in the third quarter. Barclays PLC now owns 4,574 shares of the medical instruments supplier’s stock worth $306,000 after purchasing an additional 3,118 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Utah Medical Products by 10.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 69,411 shares of the medical instruments supplier’s stock worth $4,644,000 after buying an additional 6,645 shares during the last quarter. SG Americas Securities LLC purchased a new stake in shares of Utah Medical Products during the 4th quarter valued at $157,000. R Squared Ltd purchased a new position in Utah Medical Products in the fourth quarter worth $49,000. Finally, Golden State Wealth Management LLC bought a new position in Utah Medical Products in the fourth quarter valued at $31,000. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Down 0.5 %

Shares of UTMD stock opened at $53.61 on Friday. The firm has a market cap of $175.95 million, a P/E ratio of 13.57 and a beta of 0.30. The business has a 50-day moving average price of $54.93 and a two-hundred day moving average price of $60.02. Utah Medical Products, Inc. has a 12-month low of $51.26 and a 12-month high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Tuesday, April 29th. The medical instruments supplier reported $0.92 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%. The business had revenue of $9.71 million during the quarter.

Utah Medical Products Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 3rd. Shareholders of record on Monday, June 16th will be paid a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 2.28%. The ex-dividend date is Monday, June 16th. Utah Medical Products’s dividend payout ratio is presently 32.28%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.